Logo Image

Podcasts

Recent Episodes

A multidisciplinary panel discusses the effects of GLP-1 RA use during breast cancer care along with insurance denials, costs, and other critical areas.
Exploring The Use of GLP-1 Receptor Agonists in Breast Cancer Care
Experts highlight updated findings from CARTITUDE-2, how to mitigate late toxicities, and other key considerations in the modern multiple myeloma landscape.
Discussing Guidelines, New Data, and Earlier Referrals in Multiple Myeloma
Psycho-Oncology and Palliative Care: Treating the Person, Not Just the Tumor
Psycho-Oncology and Palliative Care: Treating the Person, Not Just the Tumor
Brandon Mancini, MD, MBA, FACRO, discusses the presentations from ASTRO 2026 that may impact the future of prostate cancer, lung cancer, and other diseases.
What Data Should Radiation Oncologists Know From ASTRO 2026?
An expert panel discusses the case for de-escalating antibiotic therapy for pediatric patients who undergo hematopoietic cell transplantation.
Is Less More? Antibiotic De-Escalation in Hematopoietic Cell Transplants
Xiuning Le, MD, PhD, discusses the accelerated approval of frontline sevabertinib for patients with HER2-mutated non–small cell lung cancer.
What Does Sevabertinib’s Expanded Approval Mean for HER2+ NSCLC?
How Oncologists Can Navigate Patient Requests for Medical Aid in Dying
How Oncologists Can Navigate Patient Requests for Medical Aid in Dying
At SOHO 2026, experts highlighted new findings and advances across diseases including lymphoma, myelodysplastic syndrome, and leukemia.
What Were the Key Hematologic Oncology Takeaways from SOHO 2026?
Bladder-sparing options for BCG-unresponsive non-muscle invasive bladder cancer have transformed since 2020, according to Saum Ghodoussipour, MD.
Rethinking BCG Failure and The Bladder-Sparing Boom in NMIBC
The FDA’s decision on iberdomide is a “landmark approval” for those with multiple myeloma, according to Surbhi Sidana, MD.
Unpacking Iberdomide’s FDA Approval and The Future of CELMoDs

All series

Recent Episodes

Recent Episodes

Double Blind

Double Blind

Oncology On the Go With ASTCT Talks

Oncology On the Go With ASTCT Talks

The AI Oncology Revolution

The AI Oncology Revolution

ONCOLOGY Decoded

ONCOLOGY Decoded

RadOnc on the Run with Brandon Mancini, MD, MBA, FACRO

RadOnc on the Run with Brandon Mancini, MD, MBA, FACRO

FDA Approval Alert: The Need-to-Know

FDA Approval Alert: The Need-to-Know

Joshua Richter, MD, and Marco Davila, MD, PhD, discussed practical strategies for administering CAR T-cell therapy to patients with multiple myeloma. Their conversation touched upon key themes including navigating operational and referral workflows, dismantling access barriers to novel cellular therapies, and determining the proper candidates for treatment.

Exploring Practical CAR T Cell Use in Multiple Myeloma Care

Oncology-on-the-Go with Daniel C. McFarland, DO

Oncology-on-the-Go with Daniel C. McFarland, DO

All Podcasts